Radiopharmaceuticals are therapeutic and therapeutic agents of which radioactive nuclide is an integral part. Radiopharmaceuticals (RPP) differ from traditional medicines in the absence of any pharmacodynamic effect on the human body, which is due to the introduction of small amounts of a labeled chemical compound. The effect of therapeutic RPPs is due not to the influence of a chemical compound, but to the radiation of a radionuclide included in its structure. The diagnostic use of RPPs is based on the features of their pharmacokinetics, which allows you to obtain an image of an organ and determine its anatomical and topographic characteristics or assess the functional state of an organ or system without violating the physical conditions of its operation.
RADIONUCLIDE THERAPEUTIC DRUGS
Y-90
Appointment is an extremely powerful tool in the treatment of patients with unresectable primary cancer and not multiple metastatic liver damage
Sr-89
Appointment - external radiation therapy. For patients whose pain syndrome is poorly relieved by non-narcotic analgesics
Sm-153
Appointment - treatment of bone metastases
Lu-177
Appointment - refers to the direction of peptide receptor radionuclide therapy. This is one of the types of radiation treatment for cancer
At-211
Appointment - radiation therapy - the use of high-energy electrons, protons, neutrons and gamma quanta to "burn out" cancerous tumors in the early stages of the disease
Appointment is an extremely powerful tool in the treatment of patients with unresectable primary cancer and not multiple metastatic liver damage
Sr-89
Appointment - external radiation therapy. For patients whose pain syndrome is poorly relieved by non-narcotic analgesics
Sm-153
Appointment - treatment of bone metastases
Lu-177
Appointment - refers to the direction of peptide receptor radionuclide therapy. This is one of the types of radiation treatment for cancer
At-211
Appointment - radiation therapy - the use of high-energy electrons, protons, neutrons and gamma quanta to "burn out" cancerous tumors in the early stages of the disease
Pb-212
Appointment - targeted therapy of malignant tumors
Ra-223
Appointment - treatment of prostate cancer
Ra-224
Appointment - therapy of oncological diseases of wide application
Ra-226
Appointment - contact radiation therapy, internal radiation therapy
Ac-225
Appointment - it is one of the most promising alpha emitters for targeted therapy.
Th-227
Appointment - radio-alpha therapy
Appointment - targeted therapy of malignant tumors
Ra-223
Appointment - treatment of prostate cancer
Ra-224
Appointment - therapy of oncological diseases of wide application
Ra-226
Appointment - contact radiation therapy, internal radiation therapy
Ac-225
Appointment - it is one of the most promising alpha emitters for targeted therapy.
Th-227
Appointment - radio-alpha therapy